A novel CXCR4 antagonist for hematopoietic stem cell mobilization

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.11, 2008-11, pp. : 1749-1760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stromal Cell Derived Factor-1 / CXCL12, CXCR4 and CD26 in the Mobilization and Homing of Hematopoietic Stem and Progenitor Cells

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 4, 2004-12 ,pp. : 303-311

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3903-3920

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Preparative Regimens in Hematopoietic Stem Cell Transplantation

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1923-1935

Bentham Science Publishers

Access to resources Recommend Favorite

Biosimilar Filgrastim in Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization and Post-Transplant Hematologic Recovery

Current Medicinal Chemistry, Vol. 23, Iss. 21, 2016-08 ,pp. : 2217-2229

Bentham Science Publishers

Access to resources Recommend Favorite

The Urokinase Receptor in Hematopoietic Stem Cells Mobilization

Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. : 1911-1913

Bentham Science Publishers

Access to resources Recommend Favorite